e-learning
resources
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns
Yet H. Khor, Elisabetta A. Renzoni, Dina Visca, Christine F. McDonald, Nicole S. L. Goh
Source:
ERJ Open Res, 5 (3) 00118-2019; 10.1183/23120541.00118-2019
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yet H. Khor, Elisabetta A. Renzoni, Dina Visca, Christine F. McDonald, Nicole S. L. Goh. Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns. ERJ Open Res, 5 (3) 00118-2019; 10.1183/23120541.00118-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Fibrosing interstitial lung diseases: knowns and unknowns
Source: Eur Respir Rev, 28 (151) 180100; 10.1183/16000617.0100-2018
Year: 2019
Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021
Access for REGISTERED non-members
Year: 2021
Drug-induced interstitial lung disease: known knowns and known unknowns
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018
Oxygen therapy for interstitial lung disease: a systematic review
Source: Eur Respir Rev 2017; 26: 160080
Year: 2017
Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Multidisciplinary board for interstitial lung disease: Relevance for real life?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Interstitial lung diseases and COVID-19: myths and reality
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
Teleradiology in interstitial lung disease: first experiences
Source: International Congress 2017 – Rare diseases
Year: 2017
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Year: 2020
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Temporal variations of oscillometric reactance in COPD and ILD
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010
Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from non-responders
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015
Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
A new spirometry-based algorithm to predict occupational pulmonary restrictive impairment
Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept